Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CDA encodes an enzyme involved in pyrimidine salvaging.
Showing 10 out of 81 products:
Human Monoclonal CDA Primary Antibody for WB - ABIN1882220
Laliberté, Momparler: Human cytidine deaminase: purification of enzyme, cloning, and expression of its complementary DNA. in Cancer research 1994
Show all 5 Pubmed References
Human Monoclonal CDA Primary Antibody for WB - ABIN1882219
Demontis, Terao, Brivio, Zanotta, Bruschi, Garattini: Isolation and characterization of the gene coding for human cytidine deaminase. in Biochimica et biophysica acta 1999
Show all 5 Pubmed References
Human Polyclonal CDA Primary Antibody for IHC - ABIN965825
Gran, Bøyum, Johansen, Løvhaug, Seeberg: Growth inhibition of granulocyte-macrophage colony-forming cells by human cytidine deaminase requires the catalytic function of the protein. in Blood 1998
Show all 2 Pubmed References
The observed incomplete sister chromatid disjunction may be due to the accumulation of unreplicated DNA during mitosis in CDA-deficient cells, as reflected in the changes in centromeric DNA structure associated with the decrease in basal PARP-1 (show PARP1 Antibodies) activity.
Intracerebral microdialysis revealed that clonal NSC line to stably express cytosine deaminase (CD-NSCs) produced 5-FU locally in the brain in a 5-FC dose-dependent manner. Collectively, our results from this first-in-human study demonstrate initial safety and proof of concept regarding the ability of NSCs to target brain tumors and locally produce chemotherapy.
results indicate that rs2072671 in CDA may be an important prognostic marker in NK-AML (show RUNX1 Antibodies) patients.
tumor cell lines that are susceptible to epigenetic nucleosides overexpress cytidine deaminase (CDA); CDA converts 5hmdC and 5fdC into variants of uridine that are incorporated into DNA, resulting in accumulation of DNA damage, and ultimately, cell death
RNA expression of deoxycytidine kinase (DCK (show DCK Antibodies)), human equilibrative nucleoside transporter-1 (ENT1 (show SLC29A1 Antibodies)) and ribonucleotide reductase M1 (RRM1 (show RRM1 Antibodies)) were significantly higher and cytidine deaminase (CDA) was significantly lower in ex vivo Ara (show FOXC1 Antibodies)-C sensitive samples.
stimulation of PARP-1 (show PARP1 Antibodies) activity in CDA-deficient cells restores replication and, thus, chromosome segregation. Moreover, increasing intracellular dCTP levels generates under-replication-induced sister-chromatid bridges as efficiently as PARP-1 (show PARP1 Antibodies) knockdown
n the multivariate Cox (show COX8A Antibodies) regression analysis, we found that age at diagnosis, wild-type genotype of the CDA A79C polymorphism, and wild-type genotype of the dCK (show DCK Antibodies) C360G polymorphism were the most significant prognostic factors for predicting the risk of death
Single nucleotide polymorphisms in cytidine deaminase gene were associated with the efficacy of gemcitabine in Biliary Tract Cancer.
Polymorphisms in ABCB1 (show ABCB1 Antibodies), CDA, ENOSF1 (show ENOSF1 Antibodies),and TYMS (show TYMS Antibodies) could help to predict specific and overall severe adverse reactions to capecitabine.
miR (show MLXIP Antibodies)-484-modulated cytidine deaminase has a dual impact in promoting chemoresistance and suppressing cell proliferation in breast cancer
Data indicate that a combination cytosine deaminase (CDA)/uracil phosphoribosyltransferase protein (UPRT (show UPRT Antibodies))-expressing adipose tissue-derived mesenchymal stem cells (AT-MSCs) with lysomustine has a superior antitumor effect in the lung carcinoma model compared to monotherapies with transfected AT-MSCs or lysomustine alone.
Activation-induced cytidine deaminase (show AICDA Antibodies) plays an important role in the containment of autoimmune diseases by negative regulation of autoreactive B cells.
This gene encodes an enzyme involved in pyrimidine salvaging. The encoded protein forms a homotetramer that catalyzes the irreversible hydrolytic deamination of cytidine and deoxycytidine to uridine and deoxyuridine, respectively. It is one of several deaminases responsible for maintaining the cellular pyrimidine pool. Mutations in this gene are associated with decreased sensitivity to the cytosine nucleoside analogue cytosine arabinoside used in the treatment of certain childhood leukemias.
, CytiDine Deaminase family member (cdd-1)
, CytiDine Deaminase family member (cdd-2)
, cytidine aminohydrolase
, cytosine nucleoside deaminase
, small cytidine deaminase